ARTICLE | Clinical News
Thioureidobutyronitrile: Interim Phase I data
August 24, 2015 7:00 AM UTC
Interim data from 1 patient with stage IV thymoma in his eleventh month of treatment in an open-label, dose-escalation, U.S. Phase I trial showed that once-weekly IV Kevetrin for the first 3 weeks of ...